These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7094500)

  • 1. Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone.
    Tamsen A; Bondesson U; Dahlström B; Hartvig P
    Clin Pharmacokinet; 1982; 7(3):252-65. PubMed ID: 7094500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.
    Dahlström B; Tamsen A; Paalzow L; Hartvig P
    Clin Pharmacokinet; 1982; 7(3):266-79. PubMed ID: 7094501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple dose kinetics of ketobemidone in surgical patients.
    Bondesson U; Tamsen A; Dahlström B; Hartvig P
    Acta Anaesthesiol Scand Suppl; 1982; 74():63-5. PubMed ID: 6124080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and oral bioavailability of ketobemidone.
    Bondesson U; Arnér S; Anderson P; Boréus LO; Hartvig P
    Eur J Clin Pharmacol; 1980 Jan; 17(1):45-50. PubMed ID: 6102913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.
    Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P
    Eur J Clin Pharmacol; 1981 Feb; 19(3):217-23. PubMed ID: 7215421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose kinetics and bioavailability of ketobemidone.
    Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P
    Acta Anaesthesiol Scand Suppl; 1982; 74():59-62. PubMed ID: 6124079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the analgesic efficacy of ketobemidone and morphine for management of postoperative pain in children: a randomized, controlled study.
    Jylli L; Lundeberg S; Langius-Eklöf A; Olsson GL
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1256-9. PubMed ID: 15504185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of ketobemidone in critically ill patients.
    Al-Shurbaji A; Tokics L
    Br J Clin Pharmacol; 2002 Dec; 54(6):583-6. PubMed ID: 12492604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.
    Tamsen A; Hartvig P; Fagerlund C; Dahlström B
    Clin Pharmacokinet; 1982; 7(2):164-75. PubMed ID: 7067311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pethidine during anaesthesia and patient-controlled analgesic therapy.
    Hartvig P; Tamsen A; Fagerlund C; Dahlström B
    Acta Anaesthesiol Scand Suppl; 1982; 74():52-4. PubMed ID: 6953738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.
    Tamsen A; Hartvig P; Fagerlund C; Dahlström B
    Clin Pharmacokinet; 1982; 7(2):149-63. PubMed ID: 7067310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics after a single intravenous dose of the opioid ketobemidone in neonates.
    Lundeberg S; Stephanson N; Stiller CO; Eksborg S
    Acta Anaesthesiol Scand; 2012 Sep; 56(8):1026-31. PubMed ID: 22834454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of ketobemidone and its N-demethylated metabolite in patient plasma samples by gas chromatography mass spectrometry with selected ion monitoring.
    Bondesson U; Hartvig P; Abrahamsson L; Ahnfelt NO
    Biomed Mass Spectrom; 1983 Apr; 10(4):283-6. PubMed ID: 6133568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of ketobemidone in human breast milk.
    Gerdin E; Bondesson U; Hartvig P
    J Perinat Med; 1996; 24(3):293-5. PubMed ID: 8827580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children.
    Lundeberg S; Stephanson N; Lafolie P; Olsson GL; Stiller CO; Eksborg S
    Acta Anaesthesiol Scand; 2010 Apr; 54(4):435-41. PubMed ID: 19839946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antinociceptive effect of ketobemidone in comparison with Ketogin.
    Larsen JJ; Christensen AV
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):100-4. PubMed ID: 6687776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
    Bondesson U; Hartvig P; Danielsson B
    Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy.
    Hassan M; Svensson JO; Nilsson C; Hentschke P; Al-Shurbaji A; Aschan J; Ljungman P; Ringdén O
    Ther Drug Monit; 2000 Aug; 22(4):383-5. PubMed ID: 10942175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient controlled analgesic therapy in the early postoperative period.
    Tamsen A; Hartvig P; Dahlström B; Lindström B; Holmdahl MH
    Acta Anaesthesiol Scand; 1979 Oct; 23(5):462-70. PubMed ID: 532541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some spiro analogues of the potent analgesic ketobemidone.
    Rogers ME; Wilkinson DS; Thweatt JR; Halenda SP
    J Med Chem; 1980 Jun; 23(6):688-90. PubMed ID: 6248644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.